LOXL2 and renal fibrosis: In relatively mild renal fibrosis models such as in diabetic glomerulosclerosis [5] or cyclosporine-induced [41] renal interstitial fibrosis, LOXL2 inhibition alone is sufficient to ameliorate the progress of fibrosis.